IGMSIGM Biosciences, Inc.

Nasdaq igmbio.com


$ 10.33 $ -0.16 (-1.53 %)    

Monday, 26-Aug-2024 15:59:50 EDT
QQQ $ 474.46 $ -4.66 (-0.97 %)
DIA $ 412.48 $ 0.89 (0.22 %)
SPY $ 560.78 $ -1.34 (-0.24 %)
TLT $ 98.13 $ -0.25 (-0.25 %)
GLD $ 232.75 $ 0.74 (0.32 %)
$ 10.29
$ 10.59
$ 10.30 x 200
-- x --
$ 9.98 - $ 10.89
$ 3.81 - $ 17.70
159,793
na
610.39M
$ 0.92
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2024 06-30-2024 10-Q
2 05-08-2024 03-31-2024 10-Q
3 03-07-2024 12-31-2023 10-K
4 11-13-2023 09-30-2023 10-Q
5 08-03-2023 06-30-2023 10-Q
6 05-12-2023 03-31-2023 10-Q
7 03-30-2023 12-31-2022 10-K
8 11-03-2022 09-30-2022 10-Q
9 08-08-2022 06-30-2022 10-Q
10 05-09-2022 03-31-2022 10-Q
11 03-29-2022 12-31-2021 10-K
12 11-04-2021 09-30-2021 10-Q
13 08-09-2021 06-30-2021 10-Q
14 05-06-2021 03-31-2021 10-Q
15 03-30-2021 12-31-2020 10-K
16 11-05-2020 09-30-2020 10-Q
17 08-06-2020 06-30-2020 10-Q
18 05-07-2020 03-31-2020 10-Q
19 03-26-2020 12-31-2019 10-K
20 11-07-2019 09-30-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 truist-securities-maintains-buy-on-igm-biosciences-lowers-price-target-to-24

Truist Securities analyst Asthika Goonewardene maintains IGM Biosciences (NASDAQ:IGMS) with a Buy and lowers the price targe...

 wedbush-maintains-outperform-on-igm-biosciences-raises-price-target-to-25

Wedbush analyst Robert Driscoll maintains IGM Biosciences (NASDAQ:IGMS) with a Outperform and raises the price target from $...

 rbc-capital-reiterates-outperform-on-igm-biosciences-maintains-20-price-target

RBC Capital analyst Brian Abrahams reiterates IGM Biosciences (NASDAQ:IGMS) with a Outperform and maintains $20 price target.

 jp-morgan-maintains-neutral-on-igm-biosciences-raises-price-target-to-12

JP Morgan analyst Eric Joseph maintains IGM Biosciences (NASDAQ:IGMS) with a Neutral and raises the price target from $11 to...

 russell-2000-index-notches-strongest-week-of-year-hits-31-month-highs-outlook-is-clouded-by-feds-concerns-over-labor-market-analyst-warns

The Russell 2000 index of small caps recorded its best weekly performance since October 2023, surging over 6%, driven by lower-...

 hc-wainwright--co-reiterates-neutral-on-igm-biosciences-maintains-12-price-target

HC Wainwright & Co. analyst Robert Burns reiterates IGM Biosciences (NASDAQ:IGMS) with a Neutral and maintains $12 price...

 wedbush-reiterates-outperform-on-igm-biosciences-maintains-20-price-target

Wedbush analyst Robert Driscoll reiterates IGM Biosciences (NASDAQ:IGMS) with a Outperform and maintains $20 price target.

 igm-biosciences-q1-eps-083-inline-sales-49700k-miss-76000k-estimate

IGM Biosciences (NASDAQ:IGMS) reported quarterly losses of $(0.83) per share which met the analyst consensus estimate. This is ...

 hc-wainwright--co-reiterates-neutral-on-igm-biosciences-maintains-12-price-target

HC Wainwright & Co. analyst Robert Burns reiterates IGM Biosciences (NASDAQ:IGMS) with a Neutral and maintains $12 price...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION